Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavras

Showing results (121-130 of 312) with videos related to

Pageof 32
Sort By:
The Journal of Laboratory and Clinical Medicine|April 1, 1991
Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunctionY X Wang, R Franco, I Gavras, et al.
The American Journal of Physiology|October 1, 1982
Systemic and regional hemodynamic effects of endogenous vasopressin stimulation in ratsF Charocopos, P Hatzinikolaou, W G North, et al.
Clinical Therapeutics|July 1, 1995
Isradipine versus captopril in patients with essential hypertensionA J Manolis, I Gavras, M Pieprzak, et al.
American Journal of Medical Genetics|August 17, 1999
Mitochondrial DNA mutations in patients with orthostatic hypotensionF Schwartz, C T Baldwin, J Baima, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1991
A novel bradykinin antagonist with improved propertiesB Lammek, Y X Wang, I Gavras, et al.
Journal of Cardiovascular Pharmacology|September 1, 1982
Pre- and postsynaptic effects of SKF64139, a phenylethanolamine N-methyltransferase inhibitor, in conscious normotensive ratsB Waeber, H R Brunner, G Haeusler, et al.
Journal of Cardiovascular Pharmacology|May 1, 1989
Intravenous dilevalol in the treatment of severe hypertensionM Bursztyn, I Gavras, D J Blasucci, et al.
Peptides|September 1, 1990
A new highly potent antagonist of bradykininB Lammek, Y X Wang, I Gavras, et al.
Journal of Hypertension|June 1, 1985
Sodium chloride-induced partial inhibition in vivo of alpha 2-adrenoceptor agonist functionO Kohlmann, I Gavras, J Biollaz, et al.
Lancet (London, England)|August 10, 1974
Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881H Gavras, H R Brunner, I Gavras, et al.
Pageof 32

Showing results (121-130 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Laboratory and Clinical Medicine|April 1, 1991
Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunctionY X Wang, R Franco, I Gavras, et al.
The American Journal of Physiology|October 1, 1982
Systemic and regional hemodynamic effects of endogenous vasopressin stimulation in ratsF Charocopos, P Hatzinikolaou, W G North, et al.
Clinical Therapeutics|July 1, 1995
Isradipine versus captopril in patients with essential hypertensionA J Manolis, I Gavras, M Pieprzak, et al.
American Journal of Medical Genetics|August 17, 1999
Mitochondrial DNA mutations in patients with orthostatic hypotensionF Schwartz, C T Baldwin, J Baima, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1991
A novel bradykinin antagonist with improved propertiesB Lammek, Y X Wang, I Gavras, et al.
Journal of Cardiovascular Pharmacology|September 1, 1982
Pre- and postsynaptic effects of SKF64139, a phenylethanolamine N-methyltransferase inhibitor, in conscious normotensive ratsB Waeber, H R Brunner, G Haeusler, et al.
Journal of Cardiovascular Pharmacology|May 1, 1989
Intravenous dilevalol in the treatment of severe hypertensionM Bursztyn, I Gavras, D J Blasucci, et al.
Peptides|September 1, 1990
A new highly potent antagonist of bradykininB Lammek, Y X Wang, I Gavras, et al.
Journal of Hypertension|June 1, 1985
Sodium chloride-induced partial inhibition in vivo of alpha 2-adrenoceptor agonist functionO Kohlmann, I Gavras, J Biollaz, et al.
Lancet (London, England)|August 10, 1974
Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881H Gavras, H R Brunner, I Gavras, et al.
Pageof 32